Study summary

Purpose of the study was to assess the effect of enzalutamide on time to Prostate Specific Antigen (PSA) progression as compared to placebo in chemotherapy naïve participants with progressive metastatic prostate cancer who have failed androgen deprivation therapy.

Additional Study Details

Phase
Phase 3
Product
enzalutamide
Product
Enzalutamide
Placebo
Type
Interventional
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
395
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for An Asian study to evaluate efficacy and safety of oral enzalutamide in progressive metastatic prostate cancer participants? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    TW00303
    Taichung, Taiwan, Province of China
    Completed
    CN00109
    Wu Han, China
    Completed
    CN00112
    Beijing, China
    Withdrawn
    CN00120
    Nanjing, China
    Completed
    TW00309
    Kaohsiung, Taiwan, Province of China
    Completed
    KR00209
    Seoul, Republic of Korea
    Completed
    KR00202
    Seongnam-si, Republic of Korea
    Completed
    CN00113
    Shanghai, China
    Completed
    KR00204
    Seoul, Republic of Korea
    Completed
    CN00105
    Shanghai, China
    Completed
    CN00103
    Beijing, China
    Completed
    TW00305
    Taoyuan County, Taiwan, Province of China
    Completed
    CN00104
    Beijing, China
    Completed
    CN00119
    Soochow, China
    Completed
    CN00118
    Wenzhou, China
    Completed
    CN00106
    Beijing, China
    Completed
    TW00304
    Taipei, Taiwan, Province of China
    Completed
    CN00126
    Shanghai, China
    Completed
    KR00207
    Busan, Republic of Korea
    Completed
    CN00127
    Beijing, China
    Completed
    HK00402
    Hong Kong, Hong Kong
    Completed
    KR00214
    Anyang, Republic of Korea
    Completed
    KR00206
    Seoul, Republic of Korea
    Completed
    TW00302
    Taichung, Taiwan, Province of China
    Completed
    TW00301
    Taipei, Taiwan, Province of China
    Completed
    KR00201
    Incheon, Republic of Korea
    Completed
    CN00124
    Xi'an, China
    Completed
    KR00210
    Seoul, Republic of Korea
    Completed
    KR00215
    Seoul, Republic of Korea
    Completed
    KR00203
    Daegu, Republic of Korea
    Completed
    CN00125
    Tianjin, China
    Completed
    CN00111
    Beijing, China
    Completed
    CN00114
    Beijing, China
    Completed
    CN00115
    Beijing, China
    Completed
    KR00212
    Cheongju, Republic of Korea
    Completed
    KR00213
    Daejeon, Republic of Korea
    Completed
    TW00308
    Tainan, Taiwan, Province of China
    Completed
    TW00306
    Taipei, Taiwan, Province of China
    Completed
    CN00121
    Changsha, China
    Completed
    CN00110
    Nanjing, China
    Completed
    CN00108
    Shanghai, China
    Completed
    KR00211
    Seoul, Republic of Korea
    Completed
    CN00107
    Hangzhou, China
    Completed
    KR00208
    Seoul, Republic of Korea
    Completed
    KR00205
    Busan, Republic of Korea
    Completed
    TW00307
    Tainan, Taiwan, Province of China
    Completed
    CN00102
    Shanghai, China
    Completed
    CN00117
    Nanjing, China

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?